相关实验视频

Updated: Jun 12, 2025

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

在HBV相关的肝细胞癌中揭示与化相关的基因:一项整合性研究,包括转录组和门德尔随机化分析

Xilong Wang¹, Ke Xiao^2,3, Zhipu Liu^2,3

¹Department of Clinical Laboratory, Weifang People's Hospital, Weifang, 261000, China.

Journal of Cancer

|September 23, 2024

概括

细胞死亡机制 - - 不硫化,与肝细胞癌 (HCC) 的不良结果有关. 这项研究揭示了二硫和乙型肝炎病毒相关的HCC (HBV-HCC) 之间的遗传联系,将GYS1确定为潜在的治疗标.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
细胞生物学细胞生物学

背景情况:

不硫化症是一种新的细胞死亡途径,与肝细胞癌 (HCC) 的预后不佳有关.
在乙型肝炎病毒 (HBV-HCC) 相关的HCC中,二硫化的特定作用仍未得到充分研究.
了解这些联系对于开发针对HBV-HCC的向疗法至关重要.

研究的目的:

调查对遗传性易感性与HBV-HCC风险之间的因果关系.
为了确定HBV-HCC的预后生物标志物.
探索HBV-HCC的潜在治疗点.

主要方法:

门德尔随机化 (MR) 分析用于评估遗传因素之间的因果关系.
使用TCGA和GEO队列开发和验证预后风险评分.
在体外和体内实验来评估GYS1.1的功能作用的实验.

主要成果:

对HBV的遗传易感性会增加HCC的风险,与二硫化相关的遗传变化与HBV-HCC风险的增加有关.
五个基因的风险评分 (GYS1,RPN1,SLC7A11,LRPPRC,CAPZB) 可以准确预测HBV-HCC的预后.
GYS1与免疫透和微卫星不稳定性 (MSI) 有着强烈的正相关性,其沉默抑制了瘤的进展.

结论:

不硫化在HBV-HCC的发病过程中起着重要作用.
一个基于基因的新型风险评分可以预测HBV-HCC患者的预后.
GYS1代表了HBV-HCC的有前途的治疗标,对免疫治疗有潜在的影响.

关键词:

脱硫脱症是一种脱硫脱症.在GYS1中,GYS1是在HBV-HCC中.门德尔的随机化预测预后预测预测

更多相关视频

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Published on: February 2, 2018

相关概念视频

Alternative RNA Splicing

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...